Therapy Focused on Lowering Postprandial Glucose, Not Fasting Glucose, May Be Superior for Lowering HbA1c. IOEZ Study Group

Diabetes Care - United States
doi 10.2337/diacare.23.9.1236
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

Blood Glucose-Lowering Therapy in Adults With Type 2 Diabetes

Nurse Prescribing
2016English

Diabetes, Bone and Glucose-Lowering Agents: Basic Biology

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2017English

Deprescribing of Glucose-Lowering Medications in the Elderly

Clinical pharmacology and therapy
2019English

Lowering the Criterion for Impaired Fasting Glucose: Impact on Disease Prevalence and Associated Risk of Diabetes and Ischemic Heart Disease

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2004English

Distinct Glucose-Lowering Mechanisms of Ipragliflozin Depending on Body Weight Changes

Drugs in R and D
Pharmacology
2016English

Effects of Intensive Glucose Lowering in Type 2 Diabetes

Yearbook of Endocrinology
2009English

Correlation of Fasting and Postprandial Plasma Glucose With HbA1c in Assessing Glycemic Control; Systematic Review and Meta-Analysis

Archives of Public Health
EnvironmentalPublic HealthOccupational Health
2015English

Lipid-Lowering Therapy With Statins May Be Associated With Cataract and Cataract Operation Risks

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Clinical Characteristics of Type 2 Diabetic Patients on Basal Insulin Therapy With Adequate Fasting Glucose Control Who Do Not Achieve HbA1c Targets

Journal of Diabetes
EndocrinologyMetabolismDiabetes
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy